» Articles » PMID: 31906372

Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials

Overview
Journal Nutrients
Date 2020 Jan 8
PMID 31906372
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this systematic review is to evaluate whether the use of probiotics has any effect on the components of metabolic syndrome (MetS) before patients develop type 2 diabetes. A qualitative systematic review, following the Cochrane methodology, and a comprehensive literature search of randomized controlled trials (RCTs) were conducted in PubMed and Scopus from inception until 4 July 2019. According to our inclusion criteria, nine clinical studies were finally analyzed, corresponding to six RCTs. Probiotics intake in patients with MetS resulted in improvements in body mass index, blood pressure, glucose metabolism, and lipid profile in some studies. Regarding inflammatory biomarkers, probiotics also positively affected the soluble vascular cell adhesion molecule 1 (sVCAM-1), interleukine-6 (IL-6), tumor necrosis factor α (TNF-α), vascular endothelial growth factor (VEGF), and thrombomodulin. Despite the diversity of the published studies, the intake of probiotics for patients with MetS may offer a discrete improvement in some of the clinical characteristics of the MetS and a decrease in inflammatory biomarkers. Nevertheless, these beneficial effects seem to be marginal compared to drug therapy and a healthy lifestyle and clinically non-relevant.

Citing Articles

Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.

Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E Metabolites. 2025; 15(2).

PMID: 39997751 PMC: 11857149. DOI: 10.3390/metabo15020127.


Naturopathic Management to Taper Off Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: A Case Report.

Linder L Integr Med (Encinitas). 2025; 24(1):26-30.

PMID: 39896831 PMC: 11778319.


The Global Prevalence of Sedentary Time in Diabetes and Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Salari N, Ahmadi M, Ghasemi H, Yarani R, Mohammadi M Iran J Public Health. 2024; 53(9):2020-2029.

PMID: 39429667 PMC: 11490326. DOI: 10.18502/ijph.v53i9.16455.


The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review.

Ghanbari F, Hasani S, Aghili Z, Asgary S Food Sci Nutr. 2024; 12(7):4569-4580.

PMID: 39055176 PMC: 11266939. DOI: 10.1002/fsn3.4142.


Effects of dietary nutrients of the gut microbiota in the long-tailed dwarf hamster ().

Cao K, Tao M, Pu X, Hou Y, Ren Y, Liu W Ecol Evol. 2024; 14(6):e11507.

PMID: 38932956 PMC: 11199130. DOI: 10.1002/ece3.11507.


References
1.
. 6. Glycemic Targets: . Diabetes Care. 2018; 42(Suppl 1):S61-S70. DOI: 10.2337/dc19-S006. View

2.
Backhed F, Ding H, Wang T, Hooper L, Koh G, Nagy A . The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. PMC: 524219. DOI: 10.1073/pnas.0407076101. View

3.
Barnard N, Willett W, Ding E . The Misuse of Meta-analysis in Nutrition Research. JAMA. 2017; 318(15):1435-1436. DOI: 10.1001/jama.2017.12083. View

4.
Szulinska M, Loniewski I, van Hemert S, Sobieska M, Bogdanski P . Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial. Nutrients. 2018; 10(6). PMC: 6024794. DOI: 10.3390/nu10060773. View

5.
Stadlbauer V, Leber B, Lemesch S, Trajanoski S, Bashir M, Horvath A . Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study. PLoS One. 2015; 10(10):e0141399. PMC: 4625062. DOI: 10.1371/journal.pone.0141399. View